Skip to Content
Søg Menu

Update fra EULAR med nye data for spondylartropatier

Lars Erik Kristensen, Forskningschef, Parker instituttet, præsenterer i denne MEDtalk nye studier fra EULAR om spondylartropatier – fra diagnostiske udfordringer, komorbiditet og mortalitet til mikrobiomets betydning samt risikoen ved COVID-19.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Increased Antibiotic Use Prior to Onset of Inflammatory Arthritis

/ Maja Skov Kragsnæs / Torkell Ellingsen
AntibiotikaReumatoid artritisSpATarmmikrobiotaPsoriasis artritis

New Safety Checklist for Antirheumatic Drugs

/ Lykke Skaarup / Tue Kragstrup
Reumatoid artritisSpAPsoriasis artritisJAK-hæmmere
Nora Borislavova Vladimirova

High Prevalence of Axial Spondyloarthritis in Inflammatory Bowel Disease Patients

/ Nora Vladimirova
IBDSpA Play the Video 07:43
Astrid Jensen Damgaard

Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs

/ Astrid Jensen Damgaard
Reumatoid artritisSpA Play the Video 06:41
Latika Gupta

COVID-19 Infection is a Risk Factor for Causing Flares in Autoimmune Rheumatic Diseases Patients

/ Latika Gupta
COVID-19 Play the Video 6:07
Sofia Ramiro

ASAS-EULAR Recommendations and Bimekizumab’s Novel Action in SpA

/ Sofia Ramiro
EULAR23SCR23SpA Play the Video 06:16

SCR 2023 – Four Days of Inspiring Data and Interdisciplinary Dialogue

/ Jan Andreasen
EULAR23SCR23PsASpA

Immunosuppressed Patients with Immune-Mediated Inflammatory Diseases Benefit from High Post-Vaccination Antibody Levels Against COVID-19 

/ BestPractice Nordic
SCR23COVID-19
Lars Erik Vølund Kristensen

IL17-hæmmere i rampelyset på EULAR 2023

/ Lars Erik Kristensen
EULAR23SpAPsoriasis Play the Video 01:44
Back to top